Tag: Molecular Medicine Award

Kazunari K (kazushige) Yokoyama | Molecular Biology | Best Researcher Award

Published on by World Science Awards

Best Researcher Award

Kazunari K (kazushige) Yokoyama
Affiliation Kaohsiung Medical University
Country Taiwan
Scopus ID 7401877315
Documents 241
Citations 8,317
h-index 52
Subject Area Molecular Biology, Genetics, Cancer Biology, Stem Cell Research
Event World Science Awards
ORCID 0000-0001-8508-7587

Kazunari K (kazushige) Yokoyama
Kaohsiung Medical University, Taiwan

Kazunari K. Yokoyama, officially known as Kazushige Yokoyama, is a distinguished molecular biologist, geneticist, and biomedical researcher whose scientific contributions have significantly influenced the fields of transcription factor biology, chromatin remodeling, stem cell research, cancer biology, oxidative stress, and gene regulation. His academic career spans more than four decades across leading institutions in Japan, the United States, France, China, and Taiwan. Through pioneering studies on AP-1 transcription factors, JDP2 signaling, antisense nucleic acid technologies, and stem-cell-associated molecular mechanisms, he has established an internationally recognized scientific legacy.[1]

Abstract

Kazunari K. Yokoyama has built an internationally respected research career centered on molecular genetics, cancer biology, stem cell science, transcriptional regulation, and chromatin dynamics. His scientific contributions encompass foundational discoveries in AP-1 transcription factor signaling, JDP2-mediated transcriptional repression, oxidative stress responses, and gene regulatory networks. With more than 300 scholarly publications, over 11,760 citations, and an h-index exceeding 62, his work has generated substantial influence within molecular biology and biomedical research communities worldwide.[1]

Keywords

Molecular Biology, Genetics, Cancer Research, Stem Cell Biology, AP-1 Signaling, JDP2, Chromatin Remodeling, Gene Regulation, Oxidative Stress, Transcription Factors, Redox Biology, Biomedical Research, Antisense Technology, Cell Therapy, Environmental Medicine.

Introduction

Professor Yokoyama’s scientific journey began with formal training in agricultural chemistry and biochemical sciences before progressing into advanced molecular biology research. Following doctoral studies at the University of Tokyo, he expanded his expertise through research appointments at the Albert Einstein College of Medicine and the City of Hope National Medical Center in the United States. His subsequent leadership positions at RIKEN and Kaohsiung Medical University enabled him to establish major research programs focused on gene regulation, cancer stem cells, developmental biology, and biomedical innovation.[2]

Research Profile

The research portfolio of Professor Yokoyama reflects sustained excellence across multiple domains of molecular and cellular biology. His work has integrated fundamental biological mechanisms with translational biomedical applications. Throughout his career, he has led major scientific initiatives involving DNA banking, gene engineering, stem cell biology, and cancer therapeutics while fostering extensive international collaborations among institutions in Asia, Europe, and North America.[2]

  • Molecular Genetics and Gene Regulation
  • Cancer Stem Cell Biology
  • Transcription Factor Networks
  • Chromatin Remodeling Mechanisms
  • Oxidative Stress and Redox Signaling
  • Environmental Medicine
  • Antisense RNA and DNA Therapeutics

Research Contributions

Professor Yokoyama’s most influential scientific achievements involve the discovery and characterization of transcriptional regulatory mechanisms associated with AP-1 complexes and JDP2 signaling pathways. His studies clarified how transcription factors interact with chromatin structures to regulate cellular differentiation, proliferation, and oncogenic transformation.[3]

  • Pioneering studies on AP-1 transcription factor biology.
  • Discovery and functional characterization of JDP2-mediated transcriptional repression.
  • Advances in chromatin remodeling and epigenetic regulation.
  • Contributions to stem cell differentiation and developmental biology.
  • Development of antisense nucleic acid therapeutic strategies.
  • Research linking oxidative stress pathways to cancer progression.
  • Investigations into cancer stem-cell-targeted therapeutic approaches.

Publications

The publication record of Professor Yokoyama exceeds 300 peer-reviewed articles, reviews, and scientific reports. His work has appeared in leading journals covering molecular biology, genetics, oncology, stem cell science, and biomedical research. Several publications have become highly cited references within their respective disciplines.[1]

  • AP-1 transcription factor signaling and cellular regulation.
  • JDP2-mediated transcriptional control mechanisms.
  • Stem cell differentiation and pluripotency studies.
  • Chromatin modification and epigenetic regulation.
  • Cancer stem cell biology and therapeutic innovation.

Research Impact

The impact of Professor Yokoyama’s scholarship is reflected by more than 11,760 citations, an h-index exceeding 62, and recognition among highly influential scientists worldwide. His inclusion in internationally recognized researcher rankings and participation in global collaborative projects demonstrate sustained influence on both fundamental biological sciences and translational medicine.[1]

  • 300+ peer-reviewed publications.
  • 11,760+ scholarly citations.
  • h-index above 62.
  • International collaborations across Asia, Europe, and North America.
  • Leadership roles in DNA banking and gene engineering initiatives.

Award Suitability

Professor Kazunari K. Yokoyama demonstrates exceptional qualifications for international recognition in molecular biology and biomedical sciences. His sustained record of scientific innovation, extensive publication output, international academic leadership, and measurable scholarly impact align strongly with the evaluation criteria commonly employed by prestigious global research awards. His contributions have advanced understanding of transcriptional regulation, stem cell biology, and cancer therapeutics while providing important foundations for future biomedical discoveries.[2]

Conclusion

Kazunari K. Yokoyama’s academic career exemplifies sustained scientific excellence, leadership, and international collaboration. Through pioneering investigations in molecular genetics, transcriptional regulation, stem cell biology, and cancer research, he has established a lasting scientific legacy that continues to influence contemporary biomedical research. His scholarly achievements and contributions to global science make him a distinguished candidate for international academic recognition.[1]

References

  1. Elsevier. (n.d.). Scopus Author Details: Kazunari K. Yokoyama, Author ID 7401877315. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=7401877315
  2. Yokoyama, K.K. Curriculum Vitae and Professional Academic Record.
    https://scholar.google.com/citations?user=3JIMA5EAAAAJ&hl=en
  3. Yokoyama, K.K. et al. The AhR-NRF2-JDP2 Gene Battery and Ligand-Induced Ahr Transcriptional Activation.

Shane Scott | Molecular Biology | Best Researcher Award

Published on by World Science Awards

Dr. Shane Scott | Molecular Biology | Best Researcher Award

Medical Student from The Ohio State College of Medicine, United States

Dr. Shane Shakar Scott is a distinguished physician-scientist whose career seamlessly integrates clinical medicine, biomedical research, and health equity advocacy. Currently enrolled in the Medical Scientist Training Program (MSTP) at The Ohio State University College of Medicine, he is pursuing both an MD and a PhD. His doctoral research focuses on the cardiotoxic effects of tyrosine kinase inhibitors and the role of βII-spectrin in heart failure, contributing significantly to the field of cardio-oncology. Dr. Scott’s work has been published in reputable journals, including Heart Failure Clinics, where he co-authored a review on intracellular signaling pathways mediating tyrosine kinase inhibitor cardiotoxicity . Beyond his research, he has demonstrated leadership through roles such as National Delegate for Medical Education at the Association of American Medical Colleges (AAMC) and co-founder of the American Association of Black Physician Scientists. His commitment to mentorship and community service is evident in his involvement with various educational programs and initiatives aimed at increasing diversity in the medical field. Dr. Scott’s multifaceted contributions position him as a leading figure in advancing both scientific knowledge and social equity in healthcare.

Professional Profile

Education

Dr. Scott’s academic journey reflects a steadfast commitment to excellence and interdisciplinary scholarship. He earned his Bachelor of Science degrees in Biochemistry and Chemistry from Brandeis University, graduating with high honors. He then pursued a Master of Science in Medical Sciences at Boston University School of Medicine, where his research centered on the intracellular localization and effects of the TAAR1 receptor. Currently, Dr. Scott is enrolled in the Medical Scientist Training Program at The Ohio State University College of Medicine, undertaking both MD and PhD degrees. His doctoral dissertation, titled “Electrical and Structural Dysfunction Underlying Tyrosine Kinase Inhibitor Cardiotoxicity and βII-spectrin Deficient Heart Failure,” delves into the molecular mechanisms of cardiotoxicity associated with cancer therapies. This rigorous academic foundation equips Dr. Scott with a unique perspective that bridges basic science and clinical application, enhancing his capacity to contribute meaningfully to translational medicine.

Professional Experience

Dr. Scott’s professional experience encompasses a blend of research, teaching, and leadership roles. As a graduate trainee at the Davis Heart and Lung Research Institute, he investigated the cardiotoxic effects of tyrosine kinase inhibitors and the role of βII-spectrin in heart failure. His earlier research at the National Institute of Mental Health focused on the intracellular effects of TAAR1 activation and the axonal trafficking of tyrosine hydroxylase mRNA. In addition to his research endeavors, Dr. Scott has contributed to medical education as a lecturer and course designer, developing curricula aimed at improving awareness and equitable treatment of Black-identified patients. His leadership roles include serving as President of the OSU College of Medicine Class of 2023 and co-founding the American Association of Black Physician Scientists. These experiences underscore his dedication to advancing both scientific inquiry and social justice within the medical community.

Research Interests

Dr. Scott’s research interests lie at the intersection of cardiology, oncology, and molecular biology. He is particularly focused on understanding the mechanisms underlying cardiotoxicity induced by cancer therapies, such as tyrosine kinase inhibitors. His work explores how these treatments affect cardiac signaling pathways and contribute to structural and functional heart abnormalities. Additionally, Dr. Scott investigates the role of βII-spectrin in cardiac dyad organization and its implications for heart failure. His research aims to identify potential therapeutic targets to mitigate adverse cardiac effects in cancer patients, thereby improving their overall treatment outcomes. Through his studies, Dr. Scott contributes to the emerging field of cardio-oncology, which seeks to balance effective cancer treatment with the preservation of cardiovascular health.

Research Skills

Dr. Scott possesses a comprehensive skill set that encompasses various aspects of biomedical research. His expertise includes molecular biology techniques such as qRT-PCR, in situ hybridization, and Western blotting, which he has applied to study gene expression and protein localization. He is proficient in electrophysiological methods, having investigated arrhythmogenic mechanisms in animal models. Dr. Scott has also utilized advanced imaging techniques to assess cardiac structure and function. His experience extends to the development of organelle-targeted FRET reporters for studying intracellular signaling pathways. Furthermore, he has demonstrated competence in designing and conducting translational research studies that bridge bench science and clinical application. These skills enable Dr. Scott to contribute effectively to multidisciplinary research teams and advance our understanding of complex biomedical phenomena.

Awards and Honors

Dr. Scott’s academic and professional achievements have been recognized through numerous awards and honors. He is a recipient of the Cummins Dyche Medical Scholarship and the Viola Cranston Erb Scholarship from The Ohio State College of Medicine. His research excellence earned him the Neff MSTP Travel Award and the DHLRI Graduate Student of the Year Award Finalist designation. Dr. Scott was inducted into the Golden Humanism Honor Society, reflecting his commitment to compassionate patient care. He received the Society of Thoracic Surgery’s Looking to the Future Scholarship and was featured by the Association of American Medical Colleges in an article highlighting his resilience and determination. These accolades underscore his dedication to advancing medical science and education while exemplifying the highest standards of professionalism and humanism.

Conclusion

Dr. Shane Shakar Scott exemplifies the qualities of an outstanding researcher and leader in the medical field. His interdisciplinary approach, combining rigorous scientific investigation with a commitment to social equity, positions him as a transformative figure in healthcare. Through his research on cardiotoxicity and heart failure, Dr. Scott contributes valuable insights that have the potential to improve patient outcomes. His dedication to mentorship, education, and community service reflects a holistic understanding of the physician-scientist’s role. As he continues to bridge the gap between bench research and clinical practice, Dr. Scott’s work will undoubtedly have a lasting impact on both scientific knowledge and the well-being of diverse patient populations.

Publications Top Notes

  1. Title: Intracellular Signaling Pathways Mediating Tyrosine Kinase Inhibitor Cardiotoxicity
    Journal: Heart Failure Clinics
    Year: 2022 (June)
    DOI: 10.1016/j.hfc.2022.02.003
    Author: Shane Shakar Scott

  2. Title: In Vivo to Ex Vivo High Resolution Optical Mapping and Contrast Enhanced Magnetic Resonance Imaging to Reveal Atrial Fibrillation Drivers and Improve Identification of Arrhythmogenic Structural Substrates in Persistent Atrial Fibrillation Canine Model
    Journal: Heart Rhythm
    Year: 2021 (August)
    DOI: 10.1016/j.hrthm.2021.06.937
    Author: Shane Shakar Scott

  3. Title: Comprehensive Evaluation of Electrophysiological and 3D Structural Features of Human Atrial Myocardium with Insights on Atrial Fibrillation Maintenance Mechanisms
    Journal: Journal of Molecular and Cellular Cardiology
    Year: 2021 (February)
    DOI: 10.1016/j.yjmcc.2020.10.012
    Author: Shane Shakar Scott

  4. Title: The Local Expression and Trafficking of Tyrosine Hydroxylase mRNA in the Axons of Sympathetic Neurons
    Journal: RNA
    Year: 2016 (April)
    DOI: 10.1261/rna.053272.115
    Authors: Noreen M. Gervasi; Shane S. Scott; Armaz Aschrafi; Jenna Gale; Sanah N. Vohra; Margaret A. MacGibeny; Amar N. Kar; Anthony E. Gioio; Barry B. Kaplan

Xiaoliang Jiang | Molecular Biology | Best Scholar Award

Published on by World Science Awards

Prof. Dr. Xiaoliang Jiang | Molecular Biology | Best Scholar Award

Professor of Physiology from Institute of Laboratory Animal Sciences, China

Professor Jiang Xiaoliang is a distinguished researcher and Master’s Supervisor at the Institute of Laboratory Animal Sciences, Chinese Academy of Medical Sciences. Born in March 1987, he has built an impressive career in cardiovascular research, laboratory animal sciences, and molecular mechanisms underlying hypertension and cardiac disorders. With over a decade of dedicated research, he has contributed significantly to understanding the role of epigenetic regulation, signal transduction pathways, and disease modeling. His extensive experience in both national and international institutions has led to numerous high-impact publications in prestigious journals such as Advanced Science, Hypertension, and the Journal of the American Heart Association. Additionally, he has successfully led and participated in major research projects funded by the National Natural Science Foundation of China and the Chinese Academy of Medical Sciences. Professor Jiang’s work demonstrates a seamless integration of experimental pathology, physiology, and translational medicine. His contributions have been recognized through several awards and honors, affirming his role as a leading scholar in his field. Jiang’s continuous commitment to innovation and excellence marks him as a highly suitable candidate for distinguished research awards. His profile reflects both depth and breadth of expertise, making him a role model for aspiring scientists.

Professional Profile

Education

Professor Jiang Xiaoliang has pursued a focused and prestigious educational path aligned with his research interests in pathology, physiology, and biological sciences. He obtained his Ph.D. in Pathology and Pathophysiology from the Institute of Laboratory Animal Sciences, Chinese Academy of Medical Sciences, between September 2011 and July 2014. His doctoral studies allowed him to develop an in-depth understanding of disease mechanisms at the molecular and cellular levels, particularly within the cardiovascular system. Before his Ph.D., he earned his M.S. in Physiology from the same institute between September 2009 and July 2011, further enhancing his knowledge of bodily functions and their disruptions in disease states. His academic journey began with a B.S. in Biological Science from Shandong Normal University, completed from September 2005 to July 2009. This strong foundational background equipped him with a broad knowledge of biological principles, critical thinking skills, and experimental methodologies, setting the stage for his later specialized training. Throughout his education, Professor Jiang demonstrated academic excellence and a commitment to scientific inquiry. His educational trajectory reflects a consistent dedication to advancing his expertise in biomedical sciences, perfectly positioning him for a leading role in cutting-edge medical research.

Professional Experience

Professor Jiang Xiaoliang’s professional career is deeply rooted in the Institute of Laboratory Animal Sciences at the Chinese Academy of Medical Sciences, where he has progressively advanced through academic and research roles. Currently, he serves as a Researcher since December 2024, leading key projects and supervising postgraduate research. Previously, he was an Associate Researcher from July 2018 to December 2024, where he contributed to significant research programs and established a strong reputation in cardiovascular and hypertension research. From January 2014 to July 2018, he worked as an Assistant Researcher, during which he honed his skills in experimental design, molecular biology techniques, and disease modeling. Notably, Professor Jiang also gained international experience as a Research Assistant at the University of Maryland School of Medicine, Department of Nephrology, from August 2012 to January 2014. This exposure to an international research environment broadened his perspectives and enriched his scientific approaches. Across all his roles, Professor Jiang has demonstrated outstanding leadership, technical expertise, and a passion for translational research. His career progression reflects a consistent commitment to excellence, making significant contributions to the fields of laboratory animal science and cardiovascular medicine.

Research Interests

Professor Jiang Xiaoliang’s research interests focus primarily on cardiovascular diseases, molecular and cellular mechanisms of hypertension, cardiac hypertrophy, renal physiology, and laboratory animal model development. He is particularly interested in the epigenetic regulation of cardiac reprogramming, the role of ion channels in blood pressure regulation, and the impact of neurohormonal factors on cardiovascular health. His work explores how pathways like PI3K/Akt, PKC-mediated signaling, and Na+/H+ exchangers contribute to disease pathology, and how these mechanisms can be targeted therapeutically. Additionally, he has investigated the interplay between salt sensitivity, inflammation, and oxidative stress in the development of hypertension. Another key area of his research includes the establishment and refinement of animal models for infectious and cardiovascular diseases, aiding in the development of new therapeutic interventions. His focus on translational medicine bridges basic research findings with potential clinical applications. Furthermore, Jiang has demonstrated a keen interest in the interactions between dopamine receptor pathways and cardiovascular-renal function. Through his research, he aims to uncover novel insights that can lead to innovative treatments for complex and critical diseases.

Research Skills

Professor Jiang Xiaoliang possesses an extensive array of research skills that have greatly enhanced his scientific contributions. His expertise includes molecular biology techniques such as gene editing, nucleic acid delivery, and signal transduction pathway analysis. He is proficient in developing and utilizing animal models for cardiovascular and infectious disease studies, a critical skill in translational medicine. Jiang has demonstrated advanced capabilities in histopathology, immunohistochemistry, real-time PCR, Western blotting, and other biochemical assays essential for mechanistic studies. He is highly skilled in the analysis of epigenetic modifications and their effects on gene expression, particularly concerning cardiac reprogramming and vascular biology. Additionally, his experience includes the application of pharmacological interventions and gene therapy techniques to elucidate disease pathways and therapeutic targets. Professor Jiang’s international research experience has provided him with strong data management, statistical analysis, and collaborative project management skills. His ability to design, implement, and analyze complex experiments underscores his strength in bridging basic research with clinical relevance. Through his technical proficiency and innovative approach, Jiang continues to push the boundaries of biomedical research.

Awards and Honors

Professor Jiang Xiaoliang’s outstanding contributions to science have been recognized through numerous prestigious awards and honors. In 2022, he was awarded the “Young International Award” by the Japanese Association for Laboratory Animal Science, a testament to his significant impact on the field at an early career stage. Additionally, he received the Second Prize of the Science and Technology Achievement Award from the Chinese Association for Laboratory Animals for his role in the “Creation and Application of Animal Models for Cardiovascular Diseases.” Another notable recognition was the Second Prize of the Hebei Provincial Science and Technology Progress Award in 2019, for his work on the regulation of the Renin-Angiotensin System in multiple organ injuries. Jiang was also selected for the highly competitive Youth Talent Support Project (YESS20170157) under the China Association for Life Sciences, where he secured ¥450,000 in funding for innovative research from 2017 to 2019. These honors reflect Professor Jiang’s consistent excellence, innovation, and leadership in biomedical research. His recognition by national and international bodies illustrates his important role in advancing scientific knowledge and his strong potential for future groundbreaking contributions.

Conclusion

In conclusion, Professor Jiang Xiaoliang stands out as a highly qualified and accomplished scholar in the field of biomedical sciences, particularly cardiovascular research and laboratory animal science. His educational background, combined with extensive professional experience and a strong record of research achievements, positions him as a leader and innovator in his discipline. His ability to secure competitive funding, produce high-impact publications, and contribute meaningfully to collaborative research initiatives highlights both his scientific capabilities and leadership qualities. Professor Jiang’s recognition through various prestigious awards further attests to his contributions to the advancement of science. His research exhibits a rare combination of depth, innovation, and translational relevance. Areas where he might further strengthen his profile include expanding international collaborations and leading multi-center studies to enhance global scientific impact. Overall, Professor Jiang’s impressive career trajectory, commitment to excellence, and passion for discovery make him a strong and deserving candidate for the Best Scholar Award in Research. He embodies the qualities of an outstanding researcher who continues to make significant contributions to medical science and inspire the next generation of scientists.

Publications Top Notes

  1. Title: Enpp1 Ameliorates MAFLD by Regulating Hepatocyte Lipid Metabolism Through the AMPK/PPARα Signaling Pathway

    • Authors: Liu Xiaohui, Chen Shuai, Liu Xing, Li Yuhan, Yang Zhiwei

    • Year: 2025

  2. Title: Intestinal Gastrin/CCKBR Axis Protects Against Type 2 Diabetes by Reducing Intestinal Glucose Absorption Through the PI3K/Akt/eIF4B Signaling Pathway

    • Authors: Liu Xue, Liu Xing, Liu Yunpeng, Zhang Haizeng, Yang Zhiwei

    • Year: 2025

Mahdieh Mondanizadeh | Molecular Medicine | Best Researcher Award

Published on by World Science Awards

Dr. Mahdieh Mondanizadeh | Molecular Medicine | Best Researcher Award

Department of Biotechnology and Molecular Medicine, Faculty of Medicine, Arak University of Medical Sciences, Arak, Iran.

Dr. Mahdieh Mondanizadeh is an Associate Professor of Molecular Medicine at Arak University of Medical Sciences, Iran. With a Ph.D. in Medical Molecular Medicine from Hamedan University of Medical Sciences, her research focuses on the role of microRNAs in cancer diagnosis, treatment, and neurological disorders. Dr. Mondanizadeh has led numerous research projects and thesis works, contributing significantly to the understanding of miRNAs in various diseases, including gastric cancer, glioma, and spinal cord injuries. Her work is widely published in esteemed journals, highlighting her expertise in molecular biology and her commitment to advancing medical science. Dr. Mondanizadeh’s research has practical implications, such as the development of non-invasive diagnostic methods for cancer and the exploration of targeted therapies. Her international exposure, including a visit to the University of Adelaide, further underscores her global perspective and dedication to collaborative research.

Profile
Education

Dr. Mahdieh Mondanizadeh is a highly qualified academic and researcher in the field of molecular medicine. She earned her Ph.D. in Medical Molecular Medicine from Hamedan University of Medical Sciences, Hamedan, Iran, where she conducted significant research from 2010 to 2014. Her doctoral thesis focused on evaluating the effect of miR-124 on transcription factors involved in the proliferation and differentiation of neuronal cells. Prior to her Ph.D., Dr. Mondanizadeh completed her M.Sc. in Medical Microbiology at Qom Islamic Azad University, Qom, Iran, from 2005 to 2007, further solidifying her foundation in microbiological research. She also holds a B.Sc. in Microbiology from Arak Azad University, Arak, Iran, which she completed between 2000 and 2004. In 2012, Dr. Mondanizadeh expanded her expertise through a visitorship at the University of Adelaide, Australia, enriching her research experience and international collaboration skills.

Professional Experience

Dr. Mahdieh Mondanizadeh is an Associate Professor of Molecular Medicine at the Department of Biotechnology, Arak University of Medical Sciences, Iran. Since joining the institution in 2015, she has made significant contributions to the field of molecular medicine, focusing on the role of microRNAs in cancer diagnosis and treatment. Dr. Mondanizadeh has successfully led numerous research projects, including the development of novel diagnostic assays and the investigation of miRNA-related gene expression in various diseases. Her expertise extends to the study of molecular pathways in cancer, spinal cord injuries, and neurodegenerative diseases. Additionally, she has collaborated with international researchers and published extensively in high-impact journals. Her work is recognized for its innovation and potential to influence future medical treatments, making her a respected figure in the scientific community.

Research Interest

Mahdieh Mondanizadeh’s research interests are deeply rooted in molecular medicine, with a particular focus on the role of microRNAs (miRNAs) in various human diseases. Her work extensively explores the regulatory functions of miRNAs in cancer, neurological disorders, and infectious diseases, aiming to uncover their potential as diagnostic biomarkers and therapeutic targets. Mondanizadeh is especially interested in the molecular mechanisms underlying cancer progression, including the role of miRNAs in signal transduction pathways and gene expression regulation. Her research also extends to the study of miRNA involvement in spinal cord injuries, neurodegenerative diseases, and reproductive health issues. Additionally, she investigates the therapeutic potential of natural compounds and their effects on miRNA expression and cancer treatment. Through her research, Mondanizadeh contributes to the development of novel diagnostic tools and targeted therapies, advancing the field of personalized medicine.

Research Skills

Mahdieh Mondanizadeh is a highly skilled researcher with extensive expertise in molecular medicine and microbiology. Her research skills are demonstrated through her successful management of numerous projects focused on the role of microRNAs in cancer, neurodegenerative diseases, and infectious diseases. She excels in designing and conducting complex experiments, particularly those involving gene expression analysis, miRNA profiling, and the development of diagnostic assays. Her proficiency in molecular techniques such as real-time PCR, immunohistochemistry, and cell culture is complemented by her strong analytical abilities, allowing her to interpret data with precision and contribute to high-impact publications. Additionally, her collaborative approach and leadership in multidisciplinary research projects highlight her ability to integrate various scientific disciplines. Mondanizadeh’s commitment to advancing molecular medicine is further evidenced by her active participation in grant writing and project management, ensuring the successful completion and dissemination of her research findings.

Awards and Recognition

Dr. Mahdieh Mondanizadeh has garnered significant recognition for her impactful contributions to the field of molecular medicine and biotechnology. As an Associate Professor at Arak University of Medical Sciences, she has received multiple research grants and led numerous projects focusing on the role of microRNAs in various diseases, particularly cancer. Her innovative work in non-invasive cancer diagnostics and therapeutic strategies has earned her acclaim both nationally and internationally. Dr. Mondanizadeh has published extensively in high-impact journals, highlighting her research excellence and commitment to advancing medical science. She has also been invited to present her findings at prestigious conferences, further cementing her reputation as a leading researcher in her field. Her dedication to mentoring students and fostering a collaborative research environment has also been recognized, making her a respected figure in the academic community.

Conclusion

Mahdieh Mondanizadeh is a strong candidate for the Best Researcher Award due to her extensive research achievements, leadership in scientific projects, and significant contributions to the understanding of molecular mechanisms in disease. Enhancing the application and impact of her research findings and expanding her international collaborations could further bolster her candidacy. Overall, her work positions her as a deserving contender for this prestigious recognition.

Publications Top Notes

  1. MiRNAs related in signaling pathways of women’s reproductive diseases: an overview
    • Authors: M. Bagheri, B. Khansarinejad, M. Mondanizadeh, M. Azimi, S. Alavi
    • Year: 2024
  2. A systems biology approach and in vitro experiment indicated Rapamycin targets key cancer and cell cycle-related genes and miRNAs in triple-negative breast cancer cells
    • Authors: A. Tafti, S. Shojaei, H. Zali, S. Mohammadi-Yeganeh, M. Mondanizadeh
    • Year: 2023
    • Citations: 2
  3. Assessment of efficacy of carboxytherapy in management of skin aging through evaluation of gene expression profile: a 2-split randomized clinical trial
    • Authors: N. Bagherani, A. Firooz, A. Ghanadan, M. Mondanizadeh, G. Tavoosidana
    • Year: 2023
  4. Hsa-miR-15b-5p/miR-195-5p Controls Osteogenic Differentiation of Human Adipose-Derived Mesenchymal Stem Cells Through Regulating Indian Hedgehog Expression
    • Authors: S. Harimi, B. Khansarinejad, F. Fesahat, M. Mondanizadeh
    • Year: 2023
  5. Optimizing a Calorimetric Method for Quantitative Assessment of Alkaline Phosphatase to confirm the Osteogenic Differentiation of Mesenchymal Stem Cell
    • Authors: S. Harimi, F. Zare, F. Fesahat, M. Mondanizadeh
    • Year: 2023
  6. The role of microRNAs in diseases and related signaling pathways
    • Authors: A. Vaghf, B. Khansarinejad, E. Ghaznavi-Rad, M. Mondanizadeh
    • Year: 2022
    • Citations: 9
  7. Low Frequency of Adenovirus, Rotavirus, and Norovirus in Pediatric Diarrheal Samples from Central Iran
    • Authors: E. Abbasi, M. Mondanizadeh, A. van Belkum, E. Ghaznavi-Rad
    • Year: 2022
    • Citations: 3
  8. The role of miRNAs as a big master regulator of signaling pathways involved in lymphoblastic leukemia
    • Authors: M. Bagheri, P.Z. Sarabi, M. Mondanizadeh
    • Year: 2022
    • Citations: 3
  9. A Review of the Function of Circulating Cell Free miRNAs as Promising Biomarkers in Cancer Diagnosis, Treatment, and Metastasis
    • Authors: M. Zand, M. Mondanizadeh
    • Year: 2022
  10. Pap Smear miR-92a-5p and miR-155-5p as Potential Diagnostic Biomarkers of Squamous Intraepithelial Cervical Cancer
    • Authors: T. Azimi, M. Paryan, M. Mondanizadeh, H. Sarmadian, A. Zamani
    • Year: 2021
    • Citations: 8